SAP Regulation of Follicular Helper CD4 T Cell Development
and Humoral Immunity Is Independent of SLAM and
Fyn Kinase
1
Megan M. McCausland,* Isharat Yusuf,* Hung Tran,* Nobuyuki Ono,
†
Yusuke Yanagi,
‡
and Shane Crotty
2
*
Mutations in SH2D1A resulting in lack of SLAM-associated protein (SAP) expression cause the human genetic immunodeficiency
X-linked lymphoproliferative disease. A severe block in germinal center development and lack of long-term humoral immunity is
one of the most prominent phenotypes of SAP
mice. We show, in this study, that the germinal center block is due to an essential
requirement for SAP expression in Ag-specific CD4 T cells to develop appropriate follicular helper T cell functions. It is unknown
what signaling molecules are involved in regulation of SAP-dependent CD4 T cell help functions. SAP binds to the cytoplasmic
tail of SLAM, and we show that SLAM is expressed on resting and activated CD4 T cells, as well as germinal center B cells. In
addition, SAP can recruit Fyn kinase to SLAM. We have now examined the role(s) of the SLAM-SAP-Fyn signaling axis in in vivo
CD4 T cell function and germinal center development. We observed normal germinal center development, long-lived plasma cell
development, and Ab responses in SLAM
/
mice after a viral infection (lymphocytic choriomeningitis virus). In a separate series
of experiments, we show that SAP is absolutely required in CD4 T cells to drive germinal center development, and that
requirement does not depend on SAP-Fyn interactions, because CD4 T cells expressing SAP R78A are capable of supporting
normal germinal center development. Therefore, a distinct SAP signaling pathway regulates follicular helper CD4 T cell
differentiation, separate from the SLAM-SAP-Fyn signaling pathway regulating Th1/Th2 differentiation. The Journal of
Immunology, 2007, 178: 817– 828.
T
he gene SH2D1A (SAP/DSHP) encodes SLAM-associ-
ated protein (SAP).
3
Mutations in SH2D1A resulting in
lack of SAP expression or destabilized SAP protein are
the cause of the human genetic immunodeficiency X-linked lym-
phoproliferative disease (XLP) (1–3). XLP patients exhibit a va-
riety of immunological defects. The most notable and problematic
symptoms of SAP-deficient humans are the inability to control
EBV infection (as well as difficulties with other infections, includ-
ing measles virus, Neisseria meningitidis, and vaccinia virus), the
development of progressive hypogammaglobulinemia, and a
heightened occurrence of B cell lymphomas (4 –7). Before recent
improvements in diagnosis and treatment, most XLP patients died
before reaching adulthood.
SAP is a small SH2-domain protein expressed in CD4 T cells,
CD8 T cells, NK cells, NKT cells, and some B cells (3, 8, 9). SAP
is now known to play a role in an impressive array of lymphocyte
functions. Examination of SAP-deficient mice revealed roles for
SAP in CD8 and CD4 T cell proliferation (10 –14), T cell IFN-
production (10, 11, 15), CD4 T cell Th1/Th2 differentiation (10,
11, 16, 17), and germinal center formation, and the generation of
memory B cells (12, 18). Recent work has also shown that SAP is
essential for the development of NKT cells, both in mice and hu-
mans (19 –21). Work in XLP humans has confirmed the memory B
cell defect and germinal center defect observed in SAP
-
mice (22–
24). Separately, a collection of studies in humans have shown that
SAP plays multifaceted roles in the regulation of NK cell killing
(25–27). How does SAP regulate or influence such a wide range of
lymphocyte functions? SAP binds to the cytoplasmic tail of SLAM
(CD150) via an ITAM/ITIM-related motif termed an immunoty-
rosine switch motif (ITSM) (3, 28, 29). SLAM plays roles in cell
adhesion (via homotypic interactions), costimulation, and cytokine
synthesis (28, 30 –33). SLAM is also the primary receptor for mea-
sles virus, a highly lymphotropic virus (34 –36). A cluster of
seven receptors related to SLAM are closely grouped together
on chromosome 1 of both mice and humans. These genes are
termed the SLAM family of receptors: CD150 (SLAM), CD244
(2B4), CD229 (Ly9), CS1 (CRACC), CD48, CD84, and LY108
(NTB-A) (4, 5, 28). All of these genes encode surface receptors
with at least two ITSM motifs in their cytoplasmic tail, except
CD48, which has no cytoplasmic tail (28). Intriguingly, a major
systemic lupus erythematosus genetic susceptibility locus maps
to the SLAM family receptors in both human and mice (37, 38).
SAP is known to bind to SLAM, CD244, CD229, CD84, and
Ly108/NTB-A (3, 26, 39, 40). SAP binding to these receptors is
not identical, because SAP can bind to SLAM in the presence or
*Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, La
Jolla, CA 92037;
†
Department of Medical Biophysics and Immunology, Princess
Margaret Hospital, Toronto, Canada; and
‡
Department of Virology, Faculty of Med-
icine, Kyushu University, Fukuoka, Japan
Received for publication October 19, 2005. Accepted for publication October
27, 2006.
The costs of publication of this article were defrayed in part by the payment of page
charges. This article must therefore be hereby marked advertisement in accordance
with 18 U.S.C. Section 1734 solely to indicate this fact.
1
This work was supported in part by a Cancer Research Institute Investigator Award
(to S.C.) and a Pew Scholar Award (to S.C.).
2
Address correspondence and reprint requests to Dr. Shane Crotty, Division of Vac-
cine Discovery, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle,
La Jolla, CA 92121. E-mail address: shane@liai.org
3
Abbreviations used in this paper: SAP, SLAM-associated protein; XLP, X-linked
lymphoproliferative disease; ITSM, immunotyrosine switch motif; MHCII, MHC
class II; LCMV, lymphocytic choriomeningitis virus; PNA, peanut lectin agglutinin;
QPCR, quantitative real-time PCR; WT, wild type.
Copyright © 2007 by The American Association of Immunologists, Inc. 0022-1767/07/$2.00
The Journal of Immunology
www.jimmunol.org